June 2006 PDF Print E-mail
Kim JY, Kim DY, Kim TH, Park SY, Lee SB, Shin KH, Pyo H, Kim JY, Cho KH.  
Intensity-modulated radiotherapy with a belly board for rectal cancer.
Int J Colorectal Dis. 2006 Jun 27

Taback B, Nguyen P, Hansen N, Edwards GK, Conway K, Giuliano AE.  
Sentinel Lymph Node Biopsy for Local Recurrence of Breast Cancer After Breast-Conserving Therapy.
Ann Surg Oncol. 2006 Jun 21;

Bourhis J, Lapeyre M, Tortochaux J, Rives M, Aghili M, Bourdin S, Lesaunier F, Benassi T, Lemanski C, Geoffrois L, Lusinchi A, Verrelle P, Bardet E, Julieron M, Wibault P, Luboinski M, Benhamou E.  
Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial.
J Clin Oncol. 2006 Jun 20;24(18):2873-8.

Pockaj BA, Gallagher JG, Loprinzi CL, Stella PJ, Barton DL, Sloan JA, Lavasseur BI, Rao RM, Fitch TR, Rowland KM, Novotny PJ, Flynn PJ, Richelson E, Fauq AH.  
Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1.
J Clin Oncol. 2006 Jun 20;24(18):2836-41.

Robert N, Leyland-Jones B, Asmar L, Belt R, Ilegbodu D, Loesch D, Raju R, Valentine E, Sayre R, Cobleigh M, Albain K, McCullough C, Fuchs L, Slamon D.  
Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer.
J Clin Oncol. 2006 Jun 20;24(18):2786-92.

Smith MR, Manola J, Kaufman DS, Oh WK, Bubley GJ, Kantoff PW.  
Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapy.
J Clin Oncol. 2006 Jun 20;24(18):2723-8.

van den Bent MJ, Carpentier AF, Brandes AA, Sanson M, Taphoorn MJ, Bernsen HJ, Frenay M, Tijssen CC, Grisold W, Sipos L, Haaxma-Reiche H, Kros JM, van Kouwenhoven MC, Vecht CJ, Allgeier A, Lacombe D, Gorlia T.  
Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial.
J Clin Oncol. 2006 Jun 20;24(18):2715-22.

Intergroup Radiation Therapy Oncology Group Trial 9402; Cairncross G, Berkey B, Shaw E, Jenkins R, Scheithauer B, Brachman D, Buckner J, Fink K, Souhami L, Laperierre N, Mehta M, Curran W.  
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.
J Clin Oncol. 2006 Jun 20;24(18):2707-14.

Ahmed RL, Thomas W, Yee D, Schmitz KH.  
Randomized controlled trial of weight training and lymphedema in breast cancer survivors.
J Clin Oncol. 2006 Jun 20;24(18):2765-72

Rapiti E, Verkooijen HM, Vlastos G, Fioretta G, Neyroud-Caspar I, Sappino AP, Chappuis PO, Bouchardy C.  
Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis.
J Clin Oncol. 2006 Jun 20;24(18):2743-9. .

Szeifert GT, Atteberry DS, Kondziolka D, Levivier M, Lunsford LD.  
Cerebral metastases pathology after radiosurgery: a multicenter study.
Cancer. 2006 Jun 15;106(12):2672-81.

Wong SJ, Machtay M, Li Y.  
Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?
J Clin Oncol. 2006 Jun 10;24(17):2653-8.

Rosenthal DI, Lewin JS, Eisbruch A.  
Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer.
J Clin Oncol. 2006 Jun 10;24(17):2636-43.

Mendenhall WM, Amdur RJ, Palta JR.  
Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls.
J Clin Oncol. 2006 Jun 10;24(17):2618-23.

Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G.  
Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.
JAMA. 2006 Jun 7;295(21):2483-91.

Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Malyapa RS, Werning JW, Lansford CD, Villaret DB.  
Definitive radiotherapy for tonsillar squamous cell carcinoma.
Am J Clin Oncol. 2006 Jun;29(3):290-7.

Varlotto JM, Gerszten K, Heron DE, Comerci J, Gautam S, Selvaraj R, Lalonde R, Chura JC.  
The potential nephrotoxic effects of intensity modulated radiotherapy delivered to the para-aortic area of women with gynecologic malignancies: preliminary results.
Am J Clin Oncol. 2006 Jun;29(3):281-9.

Boschetti M, De Lucchi M, Giusti M, Spena C, Corallo G, Goglia U, Ceresola E, Resmini E, Vera L, Minuto F, Ferone D.  
Partial visual recovery from radiation-induced optic neuropathy after hyperbaric oxygen therapy in a patient with Cushing disease.
Eur J Endocrinol. 2006 Jun;154(6):813-8.

Chen AY, Vilaseca I, Hudgins PA, Schuster D, Halkar R.  
PET-CT vs contrast-enhanced CT: what is the role for each after chemoradiation for advanced oropharyngeal cancer?
Head Neck. 2006 Jun;28(6):487-95.

Han C, Liu A, Schultheiss TE, Pezner RD, Chen YJ, Wong JY.  
Dosimetric comparisons of helical tomotherapy treatment plans and step-and-shoot intensity-modulated radiosurgery treatment plans in intracranial stereotactic radiosurgery.
Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):608-16.

Nelson C, Starkschall G, Chang JY.  
The potential for dose escalation in lung cancer as a result of systematically reducing margins used to generate planning target volume.
Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):573-86.

Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B, Reni M, Brandes AA, Curschmann J, Villa S, Cairncross G, Allgeier A, Lacombe D, Stupp R.  
Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.
J Clin Oncol. 2006 Jun 1;24(16):2563-9.

Pierce LJ, Levin AM, Rebbeck TR, Ben-David MA, Friedman E, Solin LJ, Harris EE, Gaffney DK, Haffty BG, Dawson LA, Narod SA, Olivotto IA, Eisen A, Whelan TJ, Olopade OI, Isaacs C, Merajver SD, Wong JS, Garber JE, Weber BL.  
Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer.
J Clin Oncol. 2006 Jun 1;24(16):2437-43

Regis J, Metellus P, Hayashi M, Roussel P, Donnet A, Bille-Turc F.  
Prospective controlled trial of gamma knife surgery for essential trigeminal neuralgia.
J Neurosurg. 2006 Jun;104(6):913-24.

Vogelbaum MA, Angelov L, Lee SY, Li L, Barnett GH, Suh JH.  
Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin.
J Neurosurg. 2006 Jun;104(6):907-12.

Petti PL, Chuang CF, Smith V, Larson DA.  
Peripheral doses in CyberKnife radiosurgery.
Med Phys. 2006 Jun;33(6):1770-9. ]

Viola A, Major T, Julow J.  
Comparison of (125)I stereotactic brachytherapy and LINAC radiosurgery modalities based on physical dose distribution and radiobiological efficacy.
Radiat Res. 2006 Jun;165(6):695-702.

Girinsky T, van der Maazen R, Specht L, Aleman B, Poortmans P, Lievens Y, Meijnders P, Ghalibafian M, Meerwaldt J, Noordijk E.  
Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines.
Radiother Oncol. 2006 Jun;79(3):270-7.

Boehmer D, Maingon P, Poortmans P, Baron MH, Miralbell R, Remouchamps V, Scrase C, Bossi A, Bolla M; EORTC radiation oncology group.  
Guidelines for primary radiotherapy of patients with prostate cancer.
Radiother Oncol. 2006 Jun;79(3):259-69

Kirova YM, Servois V, Campana F, Dendale R, Bollet MA, Laki F, Fournier-Bidoz N, Fourquet A.  
CT-scan based localization of the internal mammary chain and supra clavicular nodes for breast cancer radiation therapy planning.
Radiother Oncol. 2006 Jun;79(3):310-5.

Geinitz H, Zimmermann FB, Thamm R, Erber C, Muller T, Keller M, Busch R, Molls M.  
Late rectal symptoms and quality of life after conformal radiation therapy for prostate cancer.
Radiother Oncol. 2006 Jun;79(3):341-7.

Han RF, Pan JG.  
Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials.
Urology. 2006 Jun;67(6):1216-23.

Berglund RK, Jones JS, Ulchaker JC, Fergany A, Gill I, Kaouk J, Klein EA.  
Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: a prospective analysis.
Urology. 2006 Jun;67(6):1253-6

Ghavamian R, Knoll A, Boczko J, Melman A.  
Comparison of operative and functional outcomes of laparoscopic radical prostatectomy and radical retropubic prostatectomy: single surgeon experience.
Urology. 2006 Jun;67(6):1241-6.

Han RF, Pan JG.  
Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials.
Urology. 2006 Jun;67(6):1216-23.

Berglund RK, Jones JS, Ulchaker JC, Fergany A, Gill I, Kaouk J, Klein EA.  
Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: a prospective analysis.
Urology. 2006 Jun;67(6):1253-6. Epub 2006 May 6.